<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>Dr Reddys Laboratories RSS Feed | Nachrichten | finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehen</description><link>http://www.finanzen.net</link><language>de-de</language><copyright>SmartHouse Media GmbH</copyright><image><url>http://finanzen.net/images/finanzen_net.gif</url><title>Finanzen.net</title><link>http://www.finanzen.net</link></image><item><title>Dr. Reddy's verbucht Gewinnrückgang </title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_verbucht_Gewinnrueckgang__728457</link><description>
Hyderabad (aktiencheck.de AG) - Der indische Generikahersteller Dr. Reddy's Laboratories Ltd. (ISIN US2561352038/ WKN 659157) verbuchte im vierten Quartal einen Umsatz- und Ergebnisrückgang. 
Wie der Pharmakonzern am Dienstag erklärte, lag der Umsatz  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_verbucht_Gewinnrueckgang__728457</guid></item><item><title>Dr. Reddy's FY08 Revenue at Rs. 50,006 Million; EBITDA at Rs. 9,736 Million</title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_FY08_Revenue_at_Rs_50_006_Million_EBITDA_at_Rs_9_736_Million_728426</link><description>Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) today 
      announced its audited financial results for the year ended March 31, 
      2008.
     FY08 Key highlights 
          --
         
           
         
          Revenues at Rs. 50 billion ($1,250  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_FY08_Revenue_at_Rs_50_006_Million_EBITDA_at_Rs_9_736_Million_728426</guid></item><item><title>Dr. Reddy's to release FY08 results on May 20, 2008</title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_to_release_FY08_results_on_May_20_2008_723440</link><description>Dr. Reddy's Laboratories (NYSE:RDY) will announce results for the Fourth 
      Quarter and Financial Year ended March 31, 2008 on Tuesday, May 20, 2008 
      after the Board Meeting. The results will be available on the Company’s 
      website www.drreddys.com  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_to_release_FY08_results_on_May_20_2008_723440</guid></item><item><title>Dr. Reddy's Announces the Completion of Two Acquisitions</title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_Announces_the_Completion_of_Two_Acquisitions_717533</link><description>Dr. Reddy’s Laboratories (NYSE:RDY) announced 
      that it has completed two acquisitions: The Dow Chemical Company’s 
      Dowpharma Small Molecules Business associated with its Mirfield and 
      Cambridge, UK sites and BASF’s pharmaceutical 
   ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_Announces_the_Completion_of_Two_Acquisitions_717533</guid></item><item><title>BASF verkauft Pharmazie-Auftragsfertigung in Shreveport an Dr. Reddy's</title><link>http://www.finanzen.net/nachricht/BASF_verkauft_Pharmazie_Auftragsfertigung_in_Shreveport_an_Dr_Reddy_s_716298</link><description>&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Hyderabad (dpa-AFX) - Der weltgrößte Chemiekonzern BASF&amp;nbsp;&amp;nbsp;verkauft seine Pharmazie-Auftragsfertigung im amerikanischen Shreveport im US-Bundesstaat Louisana. Das Geschäft mit der Herstellung von  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/BASF_verkauft_Pharmazie_Auftragsfertigung_in_Shreveport_an_Dr_Reddy_s_716298</guid></item><item><title>Dr. Reddy's Acquires BASF's Pharmaceutical Contract Manufacturing Business and Related Facility at Shreveport in the US</title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_Acquires_BASF_s_Pharmaceutical_Contract_Manufacturing_Business_and_Related_Facility_at_Shreveport_in_the_US_716290</link><description>Dr. Reddy’s Laboratories (NYSE:RDY) announced 
      today that it has signed a definitive agreement to acquire BASF’s 
      pharmaceutical contract manufacturing business and related facility in 
      Shreveport, Louisiana, USA. This transaction is  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_Acquires_BASF_s_Pharmaceutical_Contract_Manufacturing_Business_and_Related_Facility_at_Shreveport_in_the_US_716290</guid></item><item><title>Dr. Reddy's Acquires Jet Generici Srl</title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_Acquires_Jet_Generici_Srl_702587</link><description>Dr. Reddy’s Laboratories Ltd (NYSE:RDY) 
      announced today that it has acquired Jet Generici Srl, a company engaged 
      in the sale of generic finished dosages in Italy. The deal has been 
      completed via Dr. Reddy’s Italian subsidiary, 
   ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_Acquires_Jet_Generici_Srl_702587</guid></item><item><title>Dr. Reddy's Signs Definitive Agreement to Acquire Dowpharma Small Molecules Business Associated with Dow's Mirfield and Cambridge, UK Sites</title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_Signs_Definitive_Agreement_to_Acquire_Dowpharma_Small_Molecules_Business_Associated_with_Dow_s_Mirfield_and_Cambridge_UK_Sites_700711</link><description>Dr. Reddy’s Laboratories (NYSE:RDY) today 
      announced that it has entered into a definitive agreement with The Dow 
      Chemical Company (NYSE:DOW) to acquire a portion of Dowpharma Small 
      Molecules business associated with its United Kingdom  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_Signs_Definitive_Agreement_to_Acquire_Dowpharma_Small_Molecules_Business_Associated_with_Dow_s_Mirfield_and_Cambridge_UK_Sites_700711</guid></item><item><title>Dr. Reddy's Enters Into Drug Discovery Collaboration With 7TM Pharma on Selected Drug Targets</title><link>http://www.finanzen.net/nachricht/Dr_Reddy_s_Enters_Into_Drug_Discovery_Collaboration_With_7TM_Pharma_on_Selected_Drug_Targets_689915</link><description>Dr. Reddy’s Laboratories (NYSE:RDY) and 7TM 
      Pharma announced today the signing of drug discovery collaboration on 
      selected drug targets in the area of metabolic disorders.
     
      Under the terms of the agreement, Dr. Reddy’s 
       ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Dr_Reddy_s_Enters_Into_Drug_Discovery_Collaboration_With_7TM_Pharma_on_Selected_Drug_Targets_689915</guid></item><item><title>QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes</title><link>http://www.finanzen.net/nachricht/QED_International_Associates_Announces_Changes_to_the_HealthShares_TM_Composite_and_HealthShares_TM_Respiratory_Pulmonary_Indexes_689013</link><description>NEW YORK, March 6  /PRNewswire/ -- QED International Associates, Inc, administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/QED_International_Associates_Announces_Changes_to_the_HealthShares_TM_Composite_and_HealthShares_TM_Respiratory_Pulmonary_Indexes_689013</guid></item></channel></rss>
